Literature DB >> 3071218

Processing of mammalian preprogastrin-releasing peptide.

J R Reeve1, F Cuttitta, S R Vigna, J E Shively, J H Walsh.   

Abstract

The processing of preprogastrin-releasing peptide in mammalian tissues and in cultured cells takes place at discrete sites (Figure 6). Signal peptidase cleaves away the signal peptide from the amino terminus of gastrin-releasing peptide. An exopeptidase activity may remove dipeptides from the amino terminus. The amidation site (not shown in Fig. 6; see Fig. 2) has the same general sequence (Gly-Lys-Lys) seen for other amidated peptides. Cleavage after single basic residues yields gene-related products from Form I or II preproGRP. A unique non-basic cleavage yields a gene-related product from Form III preproGRP. The processing that occurs to form GRP, GRP, and GRP gene-related peptides is shown in Figure 7. ProGRP is cleaved by a series of enzymes to form GRP with an amidated carboxyl-terminal methionine (indicated by an asterisk in Fig. 7). GRP is cleaved to form the decapeptide GRP. The carboxyl-terminal flanking peptides of all three mRNA translation products are cleaved to form several gastrin-releasing peptide gene-related products. Knowledge of the processing of gastrin-releasing peptide and its gene-related products will allow synthesis of duplicates of the stored forms of these peptides, which can then be used for biological testing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3071218     DOI: 10.1111/j.1749-6632.1988.tb23872.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Gastrin-releasing peptide (GRP) in the ovine uterus: regulation by interferon tau and progesterone.

Authors:  Gwonhwa Song; M Carey Satterfield; Jinyoung Kim; Fuller W Bazer; Thomas E Spencer
Journal:  Biol Reprod       Date:  2008-04-30       Impact factor: 4.285

2.  Characteristics and clinical validity of two immunoassays for ProGRP.

Authors:  Marianne S Nordlund; Petra Stieber; Odd Terje Brustugun; David J Warren; Elisabeth Paus
Journal:  Tumour Biol       Date:  2012-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.